Mr Neil Barber

Consultant Urological Surgeon

Men's Health

Sub-specialties: Men's Health, Urology, BPH Treatment and Surgery, Prostate Cancer Diagnostics, Penoscrotal Surgery and Robotic Kidney Surgery.

Overview

bookings.urology@onewelbeck.com

02036532042

Overview

Mr Neil Barber is a Consultant Robotic and Urological Surgeon at OneWelbeck Urology, specialising in core urology, mens urinary symptoms, prostate disease and kidney cancer

About Mr Neil Barber

Mr Neil Barber was appointed as Consultant Urological Surgeon to Frimley Park Hospital in 2005 with a remit to deliver core urology but also specialist care in the fields of BPH and renal cancer, over the last 20 years, Mr Barber has been at the forefront of changes in these fields
As Director of the Frimley Renal Cancer Service overseeing the introduction of both the Da Vinci and Versius robotic platforms to the trust and the delivery of the highest number of robotic assisted partial nephrectomy per year in the UK. Having established the Frimley Benign Prostate Clinical Research Centre, Mr Barber has led and been involved in all the clinical trials in this rapidly evolving field, facilitating the introduction of Greenlight laser, Urolift, iTIND, and most recently Aquablation to the UK. He is a globally recognised key opinion leader, lecturing and teaching all over the world, including the European School of Urology, and has sat as a clinical expert for NICE for plasma TURP, Greenlight laser, Urolift, Rezum, iTIND, and Aquablation.
Mr Barber continues to lead or be involved in all ongoing and planned high quality trials in this field and as a member of the GIRFT BPH committee and working with NHS England, he has helped develop both new guidelines and patient information animations to improve BPH management and treatment across the UK. As one of the highest volume BPH surgeons in Europe, he has performed Aquablation of the prostate since 2015 and many hundreds of cases and remains enthusiastic and involved in the future development of this exciting new technology. He continues to work to bring new technology to patients across the speciality with the overarching aim to offer patients the highest quality care.

Areas of Expertise

Mr Neil Barber commonly treats:

  • Male urinary symptoms
  • Benign prostate disease (BPH)
  • Raised PSA
  • Foreskin issues
  • Male and female urinary tract infections
  • Renal (kidney) cancer

He performs a range of treatments including:

Additional Information

Memberships

  • Royal College of Surgeons (England)
  • British Association of Urological Surgeons (BAUS)
  • Royal Society of Medicine
  • Society of Benign Prostate Disease (SoBPD)

Research Highlights

Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. Gilling PJ, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Kaufman RP Jr, Badlani G, Plante M, Desai M, Doumanian L, Te AE, Roehrborn CG. Can J Urol. 2022 Feb;29(1):10960-10968.
Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study. Kadner G, Valerio M, Giannakis I, Manit A, Lumen N, Ho BSH, Alonso S, Schulman C, Barber N, Amparore D, Porpiglia F. World J Urol. 2020 Dec;38(12):3235-3244
A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk.
Miah S, Hosking-Jervis F, Connor MJ, Eldred-Evans D, Shah TT, Arya M, Barber N, Bhardwa J, Bott S, Burke D, Doherty A, Foster C, Freeman A, Hindley R, Jameson C, Karim O, Laniado M, Montgomery B, Nigam R, Punwani S, Sinclair A, Winkler M, Allen C, Ahmed HU. Eur Urol Oncol. 2019 Mar 29. pii: S2588-9311(19)30038-0.
‘Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.’ Gratzke C, Barber N, Speakman MJ, Berges R, Wetterauer U, Greene D, Sievert KD, Chapple CR, Patterson JM, Fahrenkrug L, Schoenthaler M, Sonksen J. BJU Int. 2017 May;119(5):767-775
‘A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study.’ Thomas JA, Tubaro A, Barber N et al, Eur Urol. 2016 Jan;69(1):94-102

Reviews

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.

Book a consultation

Nov 2024

MON TUE WED THU FRI SAT SUN

Appointments available on this day

Click any unavailable day to check availability with similar consultants

Major insurers served: Vitality, Aviva, WPA, Cigna, AXA, Bupa

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.

Mr Neil Barber is a Consultant Robotic and Urological Surgeon at OneWelbeck Urology, specialising in core urology, mens urinary symptoms, prostate disease and kidney cancer